Trademark: 97800703
Word
NANT CANCER VACCINE
Status
Pending
Status Code
730
Status Date
Monday, April 1, 2024
Serial Number
97800703
Mark Type
4000
Filing Date
Friday, February 17, 2023
Published for Opposition
Tuesday, August 8, 2023

Trademark Owner History
Nant Holdings IP, LLC - Owner At Publication

Classifications
44 medical services; medical information; providing a website featuring medical information in the fields of immunotherapy; providing a website featuring medical information in the fields of oncology, cancer, immuneoncology, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines biologics, cells and cell-derived preparations; providing medical and health information relating to pharmaceuticals, oncology, cancer, immuneoncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines, biologics, cells, and cell-derived preparations
"CANCER VACCINE"

Trademark Events
Apr 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 1, 2024
Teas Statement Of Use Received
Apr 1, 2024
Sou Extension 1 Granted
Apr 1, 2024
Sou Extension 1 Filed
Apr 1, 2024
Sou Teas Extension Received
Oct 3, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 8, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 8, 2023
Published For Opposition
Jul 19, 2023
Notification Of Notice Of Publication E-Mailed
Jun 29, 2023
Approved For Pub - Principal Register
Jun 29, 2023
Examiner's Amendment Entered
Jun 29, 2023
Notification Of Examiners Amendment E-Mailed
Jun 29, 2023
Examiners Amendment E-Mailed
Jun 29, 2023
Examiners Amendment -Written
Jun 29, 2023
Notification Of Non-Final Action E-Mailed
Jun 29, 2023
Non-Final Action E-Mailed
Jun 29, 2023
Non-Final Action Written
Jun 29, 2023
Notification Of Non-Final Action E-Mailed
Jun 29, 2023
Non-Final Action E-Mailed
Jun 29, 2023
Non-Final Action Written
Jun 29, 2023
Assigned To Examiner
Mar 8, 2023
New Application Office Supplied Data Entered
Feb 21, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24